Cargando…
Canada and the pharmaceutical industry in the time of COVID-19
The COVID-19 pandemic showed the close relationship between the Canadian government and the pharmaceutical industry when it came to both domestic and international issues. Domestically, the government chose to prioritize advice about vaccine acquisition from a panel of heavily conflicted people; it...
Autor principal: | Lexchin, Joel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631262/ https://www.ncbi.nlm.nih.gov/pubmed/37574784 http://dx.doi.org/10.1177/27551938231195434 |
Ejemplares similares
-
Complaints about Violations of Voluntary and Pharmaceutical Industry-Run Medicine Promotion Codes in Canada
por: Lexchin, Joel
Publicado: (2023) -
After More Than 50 Years, Pharmacare (and Dental Care) are Coming to Canada
por: Lexchin, Joel
Publicado: (2022) -
Disclosure of Pharmaceutical Industry Funding of Patient Organisations in Nordic Countries: Can Industry Self-Regulation Deliver on its Transparency Promise?
por: Pashley, Dylan, et al.
Publicado: (2022) -
A Proposal to Increase Value and Equity in the Development and Distribution of New Pharmaceuticals
por: Sorum, Paul, et al.
Publicado: (2022) -
An insight into the emerging role of regional medical advisor in the pharmaceutical industry
por: Gupta, Sandeep Kumar, et al.
Publicado: (2013)